Home/Filings/4/0000950170-25-083687
4//SEC Filing

MIGNONE ROBERTO 4

Accession 0000950170-25-083687

CIK 0000818686other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:03 PM ET

Size

11.0 KB

Accession

0000950170-25-083687

Insider Transaction Report

Form 4
Period: 2025-06-05
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2025-06-06+9,632105,315 total
  • Exercise/Conversion

    Restricted Share Units

    2025-06-069,6320 total
    Ordinary Shares (9,632 underlying)
  • Award

    Restricted Share Units

    2025-06-05+14,49214,492 total
    Ordinary Shares (14,492 underlying)
Holdings
  • Ordinary Shares

    (indirect: [see footnote])
    695,000
Footnotes (5)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]The 695,000 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Master Fund, Ltd. (the "Fund"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaims beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose.
  • [F4]Restricted share units were granted on June 6, 2024 and vested on June 6, 2025.
  • [F5]Restricted share units were granted on June 5, 2025 and vest on June 5, 2026.

Documents

1 file

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001258394

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:03 PM ET
Size
11.0 KB